Fig. 3
From: Influence of PapMV nanoparticles on the kinetics of the antibody response to flu vaccine
PapMV nanoparticles increase the number of TIV-specific plasma cells in an early response. TIV-specific IgG plasma cells were assayed by an enzyme-linked immunospot assay (ELISPOT) in the draining lymph nodes of vaccinated mice with TIV alone or together with PapMV nanoparticles. Data are shown as mean ± SEM, and significant differences are marked by **p < 0.01 and ***p < 0.001